IRIS
ZAMPINI, LUCIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.983
EU - Europa 1.793
AS - Asia 1.547
SA - Sud America 316
AF - Africa 69
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 7.716
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.894
SG - Singapore 558
CN - Cina 305
RU - Federazione Russa 300
UA - Ucraina 293
VN - Vietnam 258
BR - Brasile 249
IT - Italia 214
DE - Germania 183
SE - Svezia 178
IE - Irlanda 153
FR - Francia 124
DK - Danimarca 109
HK - Hong Kong 103
TR - Turchia 99
FI - Finlandia 93
GB - Regno Unito 63
KR - Corea 63
CA - Canada 53
IN - India 32
BD - Bangladesh 28
MA - Marocco 27
BE - Belgio 20
AR - Argentina 19
MX - Messico 19
JP - Giappone 18
PK - Pakistan 14
PL - Polonia 14
ZA - Sudafrica 13
ES - Italia 12
EC - Ecuador 11
ID - Indonesia 11
VE - Venezuela 11
CO - Colombia 10
IQ - Iraq 10
NL - Olanda 8
AT - Austria 6
CI - Costa d'Avorio 6
DZ - Algeria 6
PH - Filippine 6
PY - Paraguay 6
TN - Tunisia 6
UZ - Uzbekistan 6
PA - Panama 5
TT - Trinidad e Tobago 5
AE - Emirati Arabi Uniti 4
AU - Australia 4
CL - Cile 4
JO - Giordania 4
AL - Albania 3
AZ - Azerbaigian 3
EU - Europa 3
HN - Honduras 3
IR - Iran 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
RO - Romania 3
RS - Serbia 3
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
CH - Svizzera 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
EG - Egitto 2
IL - Israele 2
KZ - Kazakistan 2
NP - Nepal 2
QA - Qatar 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GY - Guiana 1
KG - Kirghizistan 1
KH - Cambogia 1
LB - Libano 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
PS - Palestinian Territory 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
SX - ???statistics.table.value.countryCode.SX??? 1
SY - Repubblica araba siriana 1
TW - Taiwan 1
UY - Uruguay 1
ZM - Zambia 1
Totale 7.716
Salva come PNG Salva come JPEG
Città #
Ashburn 531
Chandler 335
Singapore 335
Jacksonville 299
Fairfield 230
San Jose 230
Des Moines 154
Wilmington 152
Dublin 150
Boardman 148
Dallas 132
Woodbridge 115
Seattle 110
Houston 99
New York 99
Hong Kong 97
Ann Arbor 91
Council Bluffs 82
Ho Chi Minh City 82
Beijing 77
Cambridge 73
The Dalles 71
Hanoi 67
Los Angeles 65
Lawrence 61
Princeton 61
San Mateo 60
Lauterbourg 58
Moscow 53
Hefei 39
São Paulo 32
Turin 31
Ottawa 26
Centro 24
Milan 23
San Diego 23
Munich 20
Brussels 19
Buffalo 19
Orem 19
Helsinki 18
Turku 17
Washington 15
Tokyo 14
London 13
Santa Clara 13
Shanghai 13
Da Nang 12
Warsaw 12
Frankfurt am Main 11
Guangzhou 11
Montreal 11
Chicago 10
Rio de Janeiro 10
Belo Horizonte 9
Chennai 9
Johannesburg 9
Ancona 8
Boston 8
Brooklyn 8
Mumbai 8
Phoenix 8
Haiphong 7
Hanover 7
Miano 7
Norwalk 7
Rome 7
San Francisco 7
Wuhan 7
Abidjan 6
Atlanta 6
Columbus 6
Denver 6
Hải Dương 6
Poplar 6
Redmond 6
Stockholm 6
Toronto 6
Amsterdam 5
Campinas 5
Caracas 5
Jiaxing 5
Mexico City 5
Porto 5
Porto Alegre 5
Pune 5
Quito 5
Tashkent 5
Treviso 5
Baghdad 4
Brasília 4
Bắc Ninh 4
Calgary 4
Izmir 4
Karachi 4
Lahore 4
Manchester 4
Marche 4
Pittsburgh 4
Seoul 4
Totale 4.841
Salva come PNG Salva come JPEG
Nome #
Early biochemical effects of velmanase alfa in a 7-month-old infant with alpha-mannosidosis 270
Capillary electrophoresis separation of human milk neutral and acidic oligosaccharides derivatized with 2-aminoacridone 186
High-throughput determination of urinary hexosamines for diagnosis of mucopolysaccharidoses by capillary electrophoresis and high-performance liquid chromatography. 177
Plasmatic kinetics of dermatan sulfate during enzyme replacement therapy with iduronate-2-sulfatase in a mucopolysaccharidosis II Patient. 175
Human milk glycosaminoglycans 169
Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM 167
Caratterizzazione dei glicosaminoglicani del latte umano e del latte vaccino: risultati preliminari 162
Human milk glycosaminoglycans inhibit in vitro the adhesion of Escherichia coli and Salmonella fyris to human intestinal cells 161
Early diagnosis of mucopolysaccharidoses in developing countries: A low cost and easy execution approach 161
Effect of 6 years enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients 155
3-fucosyl-lactose inhibits the adhesion of Escherichia coli to Caco-2 cells 152
Breast milk oligosaccharides: effects of 2′-fucosyllactose and 6′-sialyllactose on the adhesion of Escherichia coli and Salmonella fyris to Caco-2 cells 146
Oligosaccharides in 4 Different Milk Groups, Bifidobacteria, and Ruminococcus obeum. 144
Preterm milk oligosaccharides during the first month of lactation 142
Prebiotics in infant formulas: biochemical characterization by thyn layer chromatography and high performance anion exchange chromatography 140
Effect of Holder Pasteurisation on Human Milk Glycosaminoglycans 135
Composition and structure elucidation of human milk glycosaminoglycans. 135
Importance of the combined urinary procedure for the diagnosis of Mucopolysaccharidoses 134
Composition and structure of glycosaminoglycans in DBS from 2-3-day-old newborns for the diagnosis of mucopolysaccharidosis 133
I prebiotici 131
ruolo dei prebiotici nel processo di ottimizzazione delle formule del commercio 130
Bisphosphonate Treatment in a Patient Affected by MPS IVA with Osteoporotic Phenotype 129
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine 128
Multiple sulfatase deficiency with neonatal manifestation. 127
Agarose-gel electrophoresis for the diagnosis of mucopolysaccharidoses 126
False positive screen test for mucopolysaccharidoses in healthy female newborns 123
I Prebiotici 122
Gli idrati del carbonio del latte umano 121
Mild mental retardation and low levels of urinary heparan sulfate in a patient with the attenuated phenotype of mucopolysaccharidosis type IIIA. 121
Plasmatic and urinary glycosaminoglycans characterization in Mucopolysaccharidosis II patient treated with enzyme-replacement therapy with idursulfate 120
On-line high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry profiling of human milk oligosaccharides dervatized with 2-aminoacridone 120
Total and single species of uronic acid-bearing glycosaminoglycans in urine of newborns of 2-3days of age for early diagnosis application 119
Effect of 6 years of enzyme replacement therapy on plasma and urine glycosaminoglycans in attenuated MPS I patients. 119
Gliadin-peptide induces Caco-2 monolayer permeability and tight junctions protein ZO-1 redistribution 118
Effects of holder pasteurization on human milk oligosaccharides. 118
Composizione e ruolo fisiologico dei carboidrati del latte umano pretermine 118
Structural characterization of chondroitin sulfate from Italian cheese Parmigiano Reggiano 117
Bone marrow transplantation in Hunter syndrome 116
Metabolic fate of milk glycosaminoglycans in breastfed and formula fed newborns 116
Oligosaccharides of human milk inhibit the adhesion of Listera monocytogenes to Caco-2 cells 115
I carboidrati del latte umano e delle formule del commercio 113
Syalil-oligosaccharides inhibit the adhesion of E. coli and S. fyrys to Caco-2 cells 112
Le malattie rare: dall'ambulatorio del pediatra alla terapia enzimatica. Le Mucopolisaccaridosi 111
Oligosaccharidesof human milk as polyfunctional nutrients 111
Human milk oligosaccharides inhibit the adhesion to Caco-2 cells of diarrheal pathogens: Escherichia coli,Vibrio cholerae and Salmonella fyris 111
Human milk glycosaminoglycans: the state of the art and future perspectives 111
Prebiotics of human milk and infant formulas 110
Gliadin, zonulin and gut permeability: effect on celiac and non-celiac mucosa and intestinal cell lines 109
Plasmatic dermatan sulfate and chondroitin sulfate determination in mucopolysaccharidoses. 108
Characterization of carbohydrates in commercial infant formulae 108
Plasmatic and urinary glycosaminoglycan profile in a patient affected by multiple sulfatase deficiency 104
Metabolic fate of human milk oligosaccharides in four different group of milk in breastfed infants 99
Human Milk Glycosaminoglycans as Possible Bioactive Substances for the Breastfed Newborn. 98
Glycosaminoglycan content in term and preterm milk during the first month of lactation 95
Modello in vitro per lo studio degli effetti della gliadina sulla permeabilità intestinale 94
Human milk glycosaminoglycans in feces of breastfed newborns: preliminary structural elucidation and possible biological role. 92
Short and reliable method for mucopolysaccharidoses diagnosis 91
Sialyl-oligosaccharides inhibit the adhesion of E. coli and S. fyrys to Caco-2 cells 86
First experience of combined enzyme replacement therapy and hematopoietic stem cell transplantation in alpha-mannosidosis 85
Metabolic fate of oligosaccharides from human milk 82
I prebiotici 81
Function of human milk oligosaccharides in the protection of newborns against infections 79
Totale 7.788
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.735
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.735
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022497 25 129 13 18 9 24 26 24 35 60 40 94
2022/20231.069 80 131 82 78 63 239 0 67 234 3 67 25
2023/2024582 97 15 31 75 75 138 4 39 6 23 2 77
2024/20251.040 99 108 57 25 33 38 112 82 216 75 107 88
2025/20262.537 219 155 113 225 252 202 468 301 207 194 75 126
2026/202769 69 0 0 0 0 0 0 0 0 0 0 0
Totale 7.788